Cargando…

A nomogram to predict the cancer‐specific survival of stage II–IV Epithelial ovarian cancer after bulking surgery and chemotherapy

OBJECTIVE: In order to predict the survival rate of ovarian cancer patients, multiple independent risk factors are integrated to establish a prognostic nomogram. METHODS: Cox analysis was used to construct the nomogram. All of the mainly independent factors, which can be used to predict 3‐year and 5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Ling, Yu, Ping, Zhang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267121/ https://www.ncbi.nlm.nih.gov/pubmed/34057318 http://dx.doi.org/10.1002/cam4.3980

Ejemplares similares

Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients
por: Li, Shunrong, et al.
Publicado: (2017)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer
por: Cheng, Hao, et al.
Publicado: (2023)

Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival
por: Dabi, Yohann, et al.
Publicado: (2020)

Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute
por: Hainsworth, John D, et al.
Publicado: (2015)

Nomograms predicting cancer-specific survival for stage IV colorectal cancer with synchronous lung metastases
por: Cheng, Pu, et al.
Publicado: (2022)

New nomograms to predict overall and cancer‐specific survival of angiosarcoma
por: Liu, Yuan‐Yuan, et al.
Publicado: (2021)

Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer
por: Zhang, Jieyun, et al.
Publicado: (2019)

A methylomics-associated nomogram predicts the overall survival risk of stage III to IV ovarian cancer
por: Wei, Xuan, et al.
Publicado: (2023)

Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer
por: Luo, Yanlin, et al.
Publicado: (2016)

Prognostic nomograms to predict overall survival and cancer‐specific survival in patients with pelvic chondrosarcoma
por: Chen, Li, et al.
Publicado: (2019)

Validation of a modified clinical risk score to predict cancer-specific survival for stage II colon cancer
por: Oliphant, Raymond, et al.
Publicado: (2015)

Nomogram forecasting 3‐, 5‐, and 8‐year overall survival and cancer‐specific survival of gingival squamous cell carcinoma
por: Yan, Lei, et al.
Publicado: (2020)

Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer‐specific survival of patients with kidney cancer
por: Zhou, Yuan, et al.
Publicado: (2020)

Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I‐II or unresected stage III pancreatic cancer
por: Ma, Sung J., et al.
Publicado: (2019)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population‐based analysis
por: Wang, Jiwei, et al.
Publicado: (2019)

A nomogram for prediction of stage III/IV gastric cancer outcome after surgery: A multicenter population‐based study
por: Gao, Zhiying, et al.
Publicado: (2020)

Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma
por: Xiao, Liang, et al.
Publicado: (2019)

Nomogram for predicting overall survival time of patients with stage IV colorectal cancer
por: Lv, Min-Yi, et al.
Publicado: (2022)

High expression of sperm-associated antigen 5 correlates with poor survival in ovarian cancer
por: Zhang, Mei, et al.
Publicado: (2020)

Development and validation of a nomogram to predict synchronous lung metastases in patients with ovarian cancer: a large cohort study
por: Yuan, Yufei, et al.
Publicado: (2020)

Nomograms for predicting long‐term overall survival and cancer‐specific survival in lip squamous cell carcinoma: A population‐based study
por: Hu, Chuan-Yu, et al.
Publicado: (2019)

Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I‐II pancreatic cancer
por: Ma, Sung Jun, et al.
Publicado: (2019)

Evaluating overall survival and competing risks of survival in patients with early‐stage breast cancer using a comprehensive nomogram
por: Xu, Yan‐Bo, et al.
Publicado: (2020)

Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma
por: Skirnisdottir, Ingiridur, et al.
Publicado: (2015)

Survival Outcomes of Patients with International Federation of Gynecology and Obstetrics Stage IV Ovarian Cancer: Cytoreduction Still Matters
por: Xiao, Yao, et al.
Publicado: (2023)

Nomograms to estimate long‐term overall survival and tongue cancer‐specific survival of patients with tongue squamous cell carcinoma
por: Li, Yun, et al.
Publicado: (2017)

Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy
por: Huo, Rong-Rui, et al.
Publicado: (2020)

Intake of dietary flavonoids and risk of epithelial ovarian cancer(1)(2)(3)(4)
por: Cassidy, Aedín, et al.
Publicado: (2014)

Development and validation of a prognostic nomogram for predicting cancer‐specific survival after radical cystectomy in patients with bladder cancer:A population‐based study
por: Yang, Zhiqiang, et al.
Publicado: (2020)

The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer
por: Zhou, Juan, et al.
Publicado: (2018)

A Suggested Modification to FIGO Stage IV Epithelial Ovarian Cancer
por: Métairie, Marie, et al.
Publicado: (2023)

Development and validation of a nomogram to predict cancer-specific survival of mucinous epithelial ovarian cancer after cytoreductive surgery
por: Ma, Guanchen, et al.
Publicado: (2023)

Prognostic Factors and a Predictive Nomogram of Cancer-Specific Survival of Epithelial Ovarian Cancer Patients with Pelvic Exenteration Treatment
por: Wang, Ting, et al.
Publicado: (2023)

Nomograms forecasting long‐term overall and cancer‐specific survival of patients with oral squamous cell carcinoma
por: Wang, Fengze, et al.
Publicado: (2018)

Significance of lymphovascular space invasion in epithelial ovarian cancer
por: Matsuo, Koji, et al.
Publicado: (2012)

Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer
por: Lim, Myong Cheol, et al.
Publicado: (2017)

A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer
por: Xu, Ke, et al.
Publicado: (2020)

Side-specific, Microultrasound-based Nomogram for the Prediction of Extracapsular Extension in Prostate Cancer
por: Pedraza, Adriana M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_12gecnj6k0ebpe5ms9rj3qna2r